Apogee Therapeutics (NASDAQ:APGE) Reaches New 1-Year High – Still a Buy?

Apogee Therapeutics Inc. (NASDAQ: APGE - Get Free Report)'s share price hit a new 52-week high on Wednesday. The stock traded as high as $89.63 and last traded at $88.47, with a volume of 559815 shares changing hands. The stock had previously closed at $86.74. Analysts Set New Price Targets Several analysts have recently weighed